Human Drugs

× UPDATE! Updated as of 27 March 2024.
Records 81 to 100 of 30205
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1176 Filgrastim Topneutor 300 mcg/mL Solution for Injection (IV/SC) Immunostimulant Xiamen Amoytop Biotech Co., Ltd. China Automatic Renewal 29 September 2021 24 August 2026
View BR-1178_PI_01.pdf BR-1178 Insulin Degludec + Insulin Aspart Ryzodeg FlexTouch 100 Units/mL (70% Insulin Degludec/30% Insulin Aspart) Solution for Injection (SC) - Novo Nordisk A/S Denmark Initial (from Monitored Release) 12 January 2023 30 September 2026
View BR-1179 Lactobacillus gasseri + Lactobacillus rhamnosus Ecovag Formulation: Each hard vaginal capsule contains: Lactobacillus gasseri EB01 strain........Min. 10^8 cfu Lactobacillus rhamnosus PB01 strain..........Min. 10^8 cfu Hard Vaginal Capsule Anti-infectives/Antiseptics Deerland Priobiotics & Enzymes A/S Denmark - 18 March 2022 20 September 2026
View BR-1180 Filgrastim Macroleuco 150 mcg/0.6 mL Solution for Injection (IV/SC) - Dong-A ST Co., Ltd. Korea Initial (Variation) 07 November 2023 07 November 2028
View BR-1181 Filgrastim Macroleuco 300 mcg/1.2 mL Solution for Injection (IV/SC) - Dong-A ST Co., Ltd. Korea Initial (Variation) 07 November 2023 07 November 2028
View BR-1182 Heparin Sodium Aprinol 25000 5000IU/mL (25000IU/5mL) Solution For Injection (IV/SC) - U-Square Lifesciences Pvt. Ltd. India - 16 March 2022 26 September 2026
View BR-1183 Heparin Sodium Aprinol 5000 1000IU/mL (5000IU/5mL) Solution For Injection (IV/SC) - U-Square Lifesciences Pvt. Ltd. India - 16 March 2022 26 September 2026
View BR-1184 Follitropin Alfa / Lutropin Alfa Pergoveris 150 IU / 75 IU Powder for Solution for Injection (SC) - Merck Serono S.A. Switzerland Renewal (Re-issuance) 02 September 2022 01 July 2026
View BR-1186 Human Coagulation Factor VIII Octanate 250 IU Powder for Solution for Intravenous Injection Plasma Fractions for Specific Use Octapharma AB Sweden Automatic Renewal 14 October 2021 11 November 2026
View BR-1187 Human Coagulation Factor VIII Octanate 1000 IU Powder for Solution for Intravenous Injection Plasma Fractions for Specific Use Octapharma AB Sweden Automatic Renewal 26 October 2021 11 November 2026
View BR-1188 Alteplase Actilyse 20 mg Powder for Solution for Infusion (IV) - Boehringer Ingelheim Pharma GmbH & Co. KG Germany Initial (Variation) 02 September 2022 02 September 2027
View BR-1189 Insulin aspart NovoRapid Flex Touch 100 IU/mL Solution for Injection (SC/IV) Antidiabetic Novo Nordisk A/S Denmark Renewal 23 May 2022 24 October 2026
View BR-1195 Filgrastim Filgen 300 mcg/mL Solution for Injection (IV/SC) IMMUNOSTIMULANT BF Biosciences Limited Pakistan Renewal 27 September 2021 04 October 2026
View BR-1196 Affinity-Purified Antibodies To Human Interferon Gamma Anaferon 3 mg Orodispersible Tablet - “NPF” Materia Medica Holding Russia - 07 March 2022 22 November 2026
View BR-1197 Menotrophin Menopur 600 IU Powder for Solution for Injection (SC) - Ferring GmbH Germany - 09 February 2022 07 December 2026
View BR-1198 Filgrastim Zarzio 30 MU/0.5mL Solution For Injection/Infusion (SC/IV) - Sandoz GmbH - Betriebsstätie / Manufacíuring Site Austria - 15 March 2022 15 December 2026
View BR-1199 Clostridium Botulinum Type A Neurotoxin complex Botox 50 Units Powder for Solution for Injection (IM) - Allergan Pharmaceuticals Ireland Ireland - 16 March 2022 13 January 2027
View BR-1207 Vedolizumab Entyvio 300 mg Powder for Concentrate for Solution for Infusion (IV) - Takeda Pharmaceutical Company Limited (Hikari Plant) Japan Initial [from Monitored Release] (Reconstruction) 16 January 2024 24 February 2027
View BR-1210 Idarucizumab Praxbind 50mg/mL Solution For Injection (IV) - Boehringer Ingelheim Pharma GmbH & Co. KG Germany - 22 April 2022 13 March 2027
View BR-1214 Human Papillomavirus 9-Valent Vaccine (Recombinant, Adsorbed) Gardasil 9 Formulation: Each dose (0.5 mL) contains: Human Papillomavirus Type 6 1.1-30 mcg protein Human Papillomavirus Type 11 1.1 protein-40 mcg Human Papillomavirus Type 16 1.1 protein-60 mcg Human Papillomavirus Type 18 1.1 protein-40 mcg Human Papillomavirus Type 31 1.1 protein-20 mcg Human Papillomavirus Type 33 1.1 protein -20 mcg Human Papillomavirus Type 45 1.1 protein -20 mcg Human Papillomavirus Type 52 1.1 protein-20 mcg Human Papillomavirus Type 58 1.1 protein-20 mcg Adsorbed on amorphous aluminum hydroxyphosphate sulphate adjuvant (500 mcg Al) Suspension for Injection (IM) - Merck Sharp & Dohme Corporation United States of America Initial (from Monitored Release) 05 August 2022 04 April 2027